191 related articles for article (PubMed ID: 29569974)
1. Efficacy of ibrutinib as first-line treatment of tumoral Bing-Neel syndrome.
Boudin L; Patient M; Roméo E; Bladé JS; de Jauréguiberry JP
Leuk Lymphoma; 2018 Nov; 59(11):2746-2748. PubMed ID: 29569974
[No Abstract] [Full Text] [Related]
2. Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report.
Hartsell L; Janes A; Larck C; Park S; Arnall JR
J Oncol Pharm Pract; 2019 Sep; 25(6):1534-1539. PubMed ID: 30760164
[TBL] [Abstract][Full Text] [Related]
3. Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.
Plander M; Szendrei T; Vadvári Á; Iványi J
Pathol Oncol Res; 2020 Jan; 26(1):591-592. PubMed ID: 30357751
[No Abstract] [Full Text] [Related]
4. First-line ibrutinib for Bing-Neel syndrome.
Tallant A; Selig D; Wanko SO; Roswarski J
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279255
[TBL] [Abstract][Full Text] [Related]
5. How we manage Bing-Neel syndrome.
Castillo JJ; Treon SP
Br J Haematol; 2019 Nov; 187(3):277-285. PubMed ID: 31430829
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
Cabannes-Hamy A; Lemal R; Goldwirt L; Poulain S; Amorim S; Pérignon R; Berger J; Brice P; De Kerviler E; Bay JO; Sauvageon H; Beldjord K; Mourah S; Tournilhac O; Thieblemont C
Am J Hematol; 2016 Mar; 91(3):E17-9. PubMed ID: 26689870
[No Abstract] [Full Text] [Related]
7. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.
Castillo JJ; Itchaki G; Paludo J; Varettoni M; Buske C; Eyre TA; Chavez JC; Shain KH; Issa S; Palomba ML; Pasvolsky O; Simpson D; Talaulikar D; Tam CS; Tedeschi A; Ansell SM; Nayak L; Treon SP
Blood; 2019 Jan; 133(4):299-305. PubMed ID: 30523119
[TBL] [Abstract][Full Text] [Related]
8. Bing-Neel syndrome: A case reports.
Demircioğlu S; Oltulu P; Emlik GD; Tekinalp A; Çeneli Ö
J Oncol Pharm Pract; 2021 Oct; 27(7):1758-1761. PubMed ID: 33356992
[TBL] [Abstract][Full Text] [Related]
9. Bing-Neel Syndrome Successfully Treated with Tirabrutinib.
Oyama T; Taoka K; Chiba A; Matsuda K; Maki H; Masamoto Y; Kurokawa M
Intern Med; 2022 Dec; 61(23):3575-3579. PubMed ID: 35569989
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome.
Mason C; Savona S; Rini JN; Castillo JJ; Xu L; Hunter ZR; Treon SP; Allen SL
Br J Haematol; 2017 Oct; 179(2):339-341. PubMed ID: 27409073
[No Abstract] [Full Text] [Related]
11. Rare case of Bing-Neel syndrome treated successfully with ibrutinib.
Hashmi H; Dhanoa JS; Emmons R
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31243026
[TBL] [Abstract][Full Text] [Related]
12. Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Jafri H; Khan I; Sidda A; Khan NAJ; Kheetan M; Griswold D; Pacioles T
J Investig Med High Impact Case Rep; 2021; 9():23247096211021228. PubMed ID: 34078157
[TBL] [Abstract][Full Text] [Related]
13.
Gustine JN; Xu L; Tsakmaklis N; Demos MG; Kofides A; Chen JG; Liu X; Munshi M; Guerrera ML; Chan GG; Patterson CJ; Keezer A; Meid K; Dubeau T; Yang G; Hunter ZR; Treon SP; Castillo JJ
Blood Adv; 2019 Oct; 3(19):2800-2803. PubMed ID: 31570491
[No Abstract] [Full Text] [Related]
14. Resolution of Waldenström Macroglobulinemia-Associated Autoimmune Hemolysis With Ibrutinib.
Tripathi A; Steingart R
J Oncol Pract; 2016 May; 12(5):490-1. PubMed ID: 27170696
[No Abstract] [Full Text] [Related]
15. CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib.
Vos JM; Tsakmaklis N; Patterson CJ; Meid K; Castillo JJ; Brodsky P; Ganz T; Pals ST; Kersten MJ; Xu L; Yang G; Treon SP; Hunter ZR
Haematologica; 2017 Nov; 102(11):e452-e455. PubMed ID: 28798070
[No Abstract] [Full Text] [Related]
16. ibrutinib (IMBRUVICA°) and Waldenström's macroglobulinaemia.
Prescrire Int; 2016 Oct; 25(175):232. PubMed ID: 30645823
[TBL] [Abstract][Full Text] [Related]
17. Ibrutinib in the management of Waldenstrom macroglobulinemia.
Yosef A; Touloukian EZ; Nambudiri VE
J Oncol Pharm Pract; 2019 Mar; 25(2):434-441. PubMed ID: 29996737
[TBL] [Abstract][Full Text] [Related]
18. Ibrutinib in pretreated Waldenström's macroglobulinaemia.
Bagcchi S
Lancet Oncol; 2015 May; 16(5):e204. PubMed ID: 25892147
[No Abstract] [Full Text] [Related]
19. Bing-Neel syndrome with a paravertebral mass.
Suzuki D; Sato D; Kikuchi K; Suzuki T; Sugasawa K; Saito S; Uchimura F; Suzuki Y
Am J Med Sci; 2023 Oct; 366(4):316-320. PubMed ID: 37473959
[TBL] [Abstract][Full Text] [Related]
20. Bing-Neel syndrome presenting with bilateral lumbar radiculopathy: A case report of a rare clinical entity.
Brotis AG; Palassopoulou M; Kapsalaki EZ; Paschalis T; Papastergiou V; Fountas KN
Neurocirugia (Astur : Engl Ed); 2022; 33(5):250-253. PubMed ID: 36084961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
